The Hormonal Link to Ocular Disease in Women - Top-Institutions - MDSpire

The Hormonal Link to Ocular Disease in Women

Neda Gioia, OD, CNS, FMCP, FOWNS, reviewed how levels of individual hormones and the balance between them help regulate tear production, inflammation, wound healing, lipid secretion, intraocular pressure (IOP), and neuroprotection, and therefore can result in a higher burden of dry eye, glaucoma, or retinal disease in women.

  • By

  • Veronica Daub

  • June 17, 2026

  • 5 min

Share

Top Institutions in Optometry

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts Eye and Ear/Schepens Eye Research Institute, Harvard Medical School
    Massachusetts Eye and Ear/Schepens Eye Research Institute, Harvard Medical School

    Boston, Massachusetts

    Key Differentiators

    • Ophthalmology

  • #2

    Wilmer Eye Institute, Johns Hopkins Medicine
    Wilmer Eye Institute, Johns Hopkins Medicine

    Baltimore, Maryland

    Key Differentiators

    • Ophthalmology

  • #3

    University of Houston College of Optometry
    University of Houston College of Optometry

    Houston, Texas

    Key Differentiators

    • Optometry

  • #4

    University of South Carolina College of Pharmacy
    University of South Carolina College of Pharmacy

    Columbia, South Carolina

    Key Differentiators

    • Pharmacy

  • #5

    First Affiliated Hospital of Fujian Medical University
    First Affiliated Hospital of Fujian Medical University

    Fuzhou, Fujian

    Key Differentiators

    • Ophthalmology

Original Source(s)

The Hormonal Link to Ocular Disease in Women

  • by Veronica Daub

  • June 17, 2026

Related Content

Mapping the FLIGHT Path

How incision-free intervention could expand glaucoma treatment options

To Build Better Treatment Plans, Listen Carefully

Providing a meaningful human experience in your practice requires some practical communication techniques

The Evolving Glaucoma Toolbox

Justin Schweitzer, OD, FAAO, and Jessica Steen, OD, FAAO, describe emerging technologies, treatment strategies, and clinical considerations that can help eyecare professionals (ECPs) identify glaucoma earlier and better manage progression.